Natera Other Share Holders Equity 2014-2025 | NTRA
Natera other share holders equity from 2014 to 2025. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Natera other share holders equity for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
- Natera other share holders equity for 2024 was $0B, a 0% decline from 2023.
- Natera other share holders equity for 2023 was $0B, a 0% decline from 2022.
- Natera other share holders equity for 2022 was $0B, a 0% decline from 2021.
| Natera Annual Other Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| Natera Quarterly Other Share Holders Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2013-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.600B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $137.516B | 25.79 |
| Elevance Health (ELV) | United States | $86.906B | 11.21 |
| CVS Health (CVS) | United States | $79.797B | 9.92 |
| Cencora (COR) | United States | $55.901B | 19.45 |
| DiDi Global (DIDIY) | China | $23.062B | 35.00 |
| BioMerieux (BMXMF) | France | $16.097B | 0.00 |
| Solventum (SOLV) | United States | $13.040B | 13.80 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.997B | 0.00 |
| CochLear (CHEOY) | Australia | $11.519B | 0.00 |
| ICON (ICLR) | Ireland | $10.888B | 10.12 |
| Doximity (DOCS) | United States | $10.770B | 49.86 |
| Revvity (RVTY) | United States | $10.667B | 18.36 |
| Viatris (VTRS) | United States | $9.929B | 3.41 |
| HealthEquity (HQY) | United States | $9.746B | 42.69 |
| Avantor (AVTR) | United States | $8.825B | 12.82 |
| Medpace Holdings (MEDP) | United States | $8.438B | 22.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.340B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.935B | 13.59 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.103B | 24.19 |
| BrightSpring Health Services (BTSG) | United States | $4.095B | 37.90 |
| Sotera Health (SHC) | United States | $3.460B | 19.66 |
| Surgery Partners (SGRY) | United States | $2.969B | 38.62 |
| Alignment Healthcare (ALHC) | United States | $2.926B | 0.00 |
| Concentras Parent (CON) | United States | $2.786B | 16.10 |
| Organon (OGN) | United States | $2.389B | 2.54 |
| Ardent Health Partners (ARDT) | United States | $2.110B | 8.99 |
| GeneDx Holdings (WGS) | United States | $1.974B | 76.01 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| Progyny (PGNY) | United States | $1.831B | 40.30 |
| PACS (PACS) | United States | $1.579B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.507B | 30.14 |
| Teladoc Health (TDOC) | United States | $1.216B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.196B | 9.10 |
| Establishment Labs Holdings (ESTA) | $1.099B | 0.00 | |
| CareDx (CDNA) | United States | $1.045B | 16.31 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.869B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.769B | 7.20 |
| QDM (QDMI) | Hong Kong, SAR China | $0.755B | 0.00 |
| Nutex Health (NUTX) | United States | $0.686B | 10.38 |
| Embecta (EMBC) | United States | $0.583B | 3.93 |
| LifeMD (LFMD) | United States | $0.549B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 44.83 |
| InnovAge Holding (INNV) | United States | $0.536B | 0.00 |
| SBC Medicals (SBC) | United States | $0.529B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.486B | 10.93 |
| Sonida Senior Living (SNDA) | United States | $0.462B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.424B | 0.00 |
| Oncology Institute (TOI) | United States | $0.249B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.235B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.146B | 23.83 |
| KindlyMD (NAKA) | United States | $0.097B | 0.00 |
| So-Young (SY) | China | $0.092B | 0.00 |
| OncoCyte (OCX) | United States | $0.085B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.060B | 0.00 |
| ModivCare (MODV) | United States | $0.060B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| Biodesix (BDSX) | United States | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |